Angola
Angola has basic but gradually developing dementia-care capacity. Major referral hospitals in Luanda provide neurology, imaging, clinical psychology, nuclear medicine and related services relevant to dementia diagnosis. The Cardeal Dom Alexandre do Nascimento hospital is particularly important because its formal structure includes neurology, imaging, nuclear medicine and advanced laboratory services. The Ministry of Health is also beginning to incorporate Alzheimer’s disease explicitly into neuroscience capacity-building, and specialist training in neurology and geriatrics is expanding.
The principal weaknesses are the absence of a standardized national dementia pathway, no dedicated dementia strategy, no national registry, limited access to advanced biomarkers, major geographic inequalities and weak dementia-specific caregiver support. WHO continues to identify substantial health-financing and access problems, including high out-of-pocket costs. Family members therefore remain central to long-term dementia care.

AD Rating
Diagnostic Pathway
Specialized Care
Caregiver Support
National Policies
Access to ATT-s
Highlights
Population
Median age
Health expenditure (% of GDP)
Diagnosis
Diagnosis
Show moreAngola’s dementia diagnostic system remains under development, with no nationally standardised pathway or mandated cognitive screening tool. Assessment may combine clinical and functional evaluation, MMSE or MoCA, laboratory testing, neurology or psychiatry referral, and CT/MRI where accessible. The Cardeal Dom Alexandre do Nascimento hospital has relatively broad neurological and diagnostic capacity, including neurology, imaging, nuclear medicine, psychology, and laboratory services, but advanced services remain concentrated in major urban and referral centres. There is no evidence that APOE or familial Alzheimer’s genetic testing is routine, and APP, PSEN1, or PSEN2 testing would likely require research, private specialist arrangements, or external referral. Waiting times are not nationally reported, while geographical disparities and workforce limitations can delay assessment outside Luanda. Although some public services are subsidised, patients may incur substantial costs for private consultations, imaging, medicines, and transportation. Capacity is gradually expanding through specialist medical training and a 2025 national neuroscience initiative identifying Alzheimer’s disease among conditions requiring strengthened technical expertise.

Diagnosis pathway
Angola has no nationally standardised dementia diagnostic pathway. Assessment may include clinical, cognitive, functional, and laboratory evaluation, followed by neurology or psychiatry referral and CT or MRI where accessible. Specialist and diagnostic capacity is concentrated particularly in Luanda, although recent neuroscience initiatives aim to strengthen national expertise in Alzheimer’s disease and other neurological conditions.
Angola does not appear to have a nationally standardized dementia diagnostic pathway. Where specialist services are available, patients may be referred to neurology or psychiatry for further evaluation, with CT or MRI performed when necessary and accessible, particularly at larger referral hospitals. Access to more complex neurological assessment and diagnostic technology remains concentrated in major urban centres, especially Luanda. The practical pathway can therefore be summarized as initial medical assessment followed by cognitive and functional evaluation, laboratory testing, specialist referral and neuroimaging where available, leading to diagnosis, symptomatic treatment and family or social support.
The Complexo Hospitalar de Doenças Cardiopulmonares Cardeal Dom Alexandre do Nascimento formally includes neurology, neurosurgery, internal medicine, diagnostic imaging, nuclear medicine, clinical psychology and laboratory diagnostics. The Ministry of Health has also started explicitly strengthening dementia-related neurological capacity. In July 2025, a national neuroscience initiative identified Alzheimer’s disease, Parkinson’s disease, stroke, epilepsy and neuropathies among the neurological conditions requiring expanded technical capacity.
- https://www.who.int/publications/i/item/9789290235057
- https://extranet.who.int/cpcd/national-health-policy-strategy-and-plan/countries/ang/planning-cycles
- https://angolex.com/paginas/decreto-executivo/estatuto-organico-do-complexo-hospitalar-de-doencas-cardiopulmonares-cardeal-dom-alexandre-do-nascimento-174a-22a.html
- https://minsa.gov.ao/web/noticias/professor-fernando-cendes-visita-angola-no-ambito-do-reforco-das-capacidades-tecnicas-em-neurociencias
Wait times
Angola has no national dementia-specific waiting-time indicators. Workforce shortages and geographically concentrated specialist and imaging services can delay assessment, especially outside Luanda, while faster private-sector access may increase household costs.
Angola does not publish national dementia-specific waiting-time data. Waiting times are likely to vary substantially according to geography, specialist availability and the patient’s ability to pay for private care. WHO continues to identify health-worker shortages, uneven access and limited system capacity as major structural challenges. Patients living outside Luanda or other major urban centres may need to travel considerable distances for neurology, CT, MRI or specialist assessment. Private-sector services may sometimes provide faster access, but this shifts a larger share of the financial burden onto households.
Diagnosis cost
Although Angola subsidises some public diagnostic services, dementia assessment can involve substantial out-of-pocket costs. Patients may pay for specialist consultations, laboratory tests, CT or MRI, medicines, and transport when public provision is unavailable.
Public-sector consultations and investigations can be subsidized or provided through state hospitals, but Angola does not provide comprehensive financial protection across the entire diagnostic pathway. WHO’s health-financing review identifies high out-of-pocket expenditure and inadequate financial protection as persistent problems in Angola. Patients may therefore pay for private specialist consultations, laboratory tests, imaging, medicines and transportation when public-sector services are unavailable or geographically distant. For dementia, this is particularly important because a complete diagnosis may require several consultations plus CT/MRI and specialist review.
Cognitive tests
There is no evidence of a nationally mandated dementia cognitive screening instrument. Neurologists, psychiatrists and trained physicians can use conventional tools such as the MMSE, MoCA or similar bedside cognitive assessments, but no evidence was found of universal standardized use across the national public system. Formal neuropsychological assessment is likely to be concentrated in larger hospitals and specialist centres. Angola is expanding specialist medical training. The 2025 medical internship framework formally includes specialties such as Neurology, Geriatrics and Psychiatry, which may gradually strengthen the country’s capacity to assess cognitive disorders.
Imaging tests
CT and MRI are available in Angola, particularly at tertiary hospitals and private diagnostic centres. The Cardeal Dom Alexandre do Nascimento hospital includes both an Imaging Service and a Nuclear Medicine Service within its formal structure. The same hospital has undergone major modernization and is equipped for high-complexity neurological and neurosurgical care, serving referred patients from several provinces. This means structural neuroimaging needed for dementia differential diagnosis is technically available. However, CT and MRI should not be described as universally or easily accessible nationwide because availability is concentrated in major urban and referral centres.
Genetic tests
There is no evidence that APOE testing or familial Alzheimer genetic testing is routinely incorporated into dementia diagnosis in Angola. Testing for APP, PSEN1 or PSEN2 mutations would therefore be exceptional and would most likely occur through research, private specialist arrangements or external referral. Routine genetic testing should not currently be considered part of Angola’s standard dementia pathway.
Biomarker tests
There is no evidence that CSF amyloid-β/tau testing, plasma phosphorylated-tau assays, amyloid PET or tau PET are routinely used in clinical dementia diagnosis in Angola. The existence of nuclear medicine infrastructure at tertiary hospitals shows broader technical capacity, but it does not demonstrate routine amyloid PET availability. The Ministry of Health’s current neuroscience programme is focused primarily on strengthening broader neurology and neurophysiology capacity, including care for Alzheimer’s disease. Advanced molecular dementia diagnostics therefore remain very limited and non-routine.
- https://angolex.com/paginas/decreto-executivo/estatuto-organico-do-complexo-hospitalar-de-doencas-cardiopulmonares-cardeal-dom-alexandre-do-nascimento-174a-22a.html
- https://minsa.gov.ao/web/noticias/professor-fernando-cendes-visita-angola-no-ambito-do-reforco-das-capacidades-tecnicas-em-neurociencias
Cognitive Tests
Cognitive Tests
There is no evidence of a nationally mandated dementia cognitive screening instrument. Neurologists, psychiatrists and trained physicians can use conventional tools such as the MMSE, MoCA or similar bedside cognitive assessments, but no evidence was found of universal standardized use across the national public system. Formal neuropsychological assessment is likely to be concentrated in larger hospitals and specialist centres. Angola is expanding specialist medical training. The 2025 medical internship framework formally includes specialties such as Neurology, Geriatrics and Psychiatry, which may gradually strengthen the country’s capacity to assess cognitive disorders.
Imaging Tests
Imaging Tests
CT and MRI are available in Angola, particularly at tertiary hospitals and private diagnostic centres. The Cardeal Dom Alexandre do Nascimento hospital includes both an Imaging Service and a Nuclear Medicine Service within its formal structure. The same hospital has undergone major modernization and is equipped for high-complexity neurological and neurosurgical care, serving referred patients from several provinces. This means structural neuroimaging needed for dementia differential diagnosis is technically available. However, CT and MRI should not be described as universally or easily accessible nationwide because availability is concentrated in major urban and referral centres.
Genetic Tests
Genetic Tests
There is no evidence that APOE testing or familial Alzheimer genetic testing is routinely incorporated into dementia diagnosis in Angola. Testing for APP, PSEN1 or PSEN2 mutations would therefore be exceptional and would most likely occur through research, private specialist arrangements or external referral. Routine genetic testing should not currently be considered part of Angola’s standard dementia pathway.
Biomarker Tests
Biomarker Tests
There is no evidence that CSF amyloid-β/tau testing, plasma phosphorylated-tau assays, amyloid PET or tau PET are routinely used in clinical dementia diagnosis in Angola. The existence of nuclear medicine infrastructure at tertiary hospitals shows broader technical capacity, but it does not demonstrate routine amyloid PET availability. The Ministry of Health’s current neuroscience programme is focused primarily on strengthening broader neurology and neurophysiology capacity, including care for Alzheimer’s disease. Advanced molecular dementia diagnostics therefore remain very limited and non-routine.
- https://angolex.com/paginas/decreto-executivo/estatuto-organico-do-complexo-hospitalar-de-doencas-cardiopulmonares-cardeal-dom-alexandre-do-nascimento-174a-22a.html
- https://minsa.gov.ao/web/noticias/professor-fernando-cendes-visita-angola-no-ambito-do-reforco-das-capacidades-tecnicas-em-neurociencias
Treatment & Care
Treatment & care
Show moreAngola’s dementia care system remains generalist, limited, and heavily reliant on families. There is no identified nationwide network of memory clinics or dedicated dementia centres; assessment and management are instead integrated into primary care, neurology, psychiatry, and internal medicine. Major referral facilities such as the Complexo Hospitalar Cardeal Dom Alexandre do Nascimento provide broader specialist capacity, while Alzheimer’s dementia is also recorded within mental-health services. However, low reported case numbers relative to expected prevalence may indicate substantial underdiagnosis or under-recording. Formal long-term and caregiver support is similarly non-specialised. MASFAMU oversees community and residential services for older people, including 18 homes across 11 provinces accommodating around 852 residents, alongside programmes such as Idoso no Lar and Idoso na Comunidade. AASTI provides additional social and psychological assistance, but there is no identified statutory dementia-specific long-term-care entitlement or comprehensive system of caregiver allowances, respite, counselling, or specialised education. Consequently, families remain responsible for much of the practical and financial burden of dementia care, including supervision, transport, household assistance, and institutional costs.
Specialized facilities and services
Angola has limited specialised dementia infrastructure, with no identified nationwide network of memory clinics or dedicated dementia centres. Assessment and management are integrated into primary care, neurology, psychiatry, and internal medicine, while complex cases can be referred to major hospitals such as the Complexo Hospitalar Cardeal Dom Alexandre do Nascimento in Luanda. Its services include neurology, neurosurgery, clinical psychology, imaging, nuclear medicine, and advanced laboratory diagnostics, with recent modernisation expanding specialist capacity. Although Alzheimer’s dementia is recorded within mental-health services, reported case numbers appear low relative to expected prevalence, suggesting that underdiagnosis or under-recording may be significant. Long-term care is also generalist: MASFAMU oversees residential services for older people, including 18 homes across 11 provinces accommodating approximately 852 residents. These facilities are not dementia-specific, leaving people with dementia reliant on broader medical, psychiatric, and social-care provision.
Angola does not appear to have a nationwide network of dedicated memory clinics or dementia centres, with dementia assessment and management instead incorporated into general neurology, psychiatry, internal medicine and primary healthcare services. More complex neurological assessment is available at major referral hospitals, including the Complexo Hospitalar Cardeal Dom Alexandre do Nascimento in Luanda, whose services include neurology, neurosurgery, internal medicine, clinical psychology, diagnostic imaging, nuclear medicine and advanced laboratory diagnostics. Recent investment and modernization have expanded the hospital’s capacity to manage complex neurological and other specialist conditions.
Dementia may also be managed through psychiatric and mental-health services, particularly when behavioural or psychological symptoms are present. Notably, official Angolan health statistics include “Dementia of Alzheimer’s Disease” among conditions recorded by mental-health services, although the relatively small number of reported cases compared with expected population prevalence suggests that many cases may remain undiagnosed or unrecorded.
Long-term social care for people with dementia is largely embedded within Angola’s broader services for older and vulnerable people rather than provided through dementia-specific facilities. The Ministry of Social Action, Family and Women’s Promotion (MASFAMU) oversees social-protection programmes for older people, including residential provision. Government reporting has identified 18 residential homes for older people across 11 provinces, accommodating approximately 852 residents at the time of reporting. These institutions are not specifically designed as dementia-care facilities, but they form part of the limited formal long-term-care infrastructure potentially available to older people experiencing cognitive and functional impairment. Consequently, Angola’s dementia-care capacity remains largely integrated into general medical, psychiatric and social-care structures rather than organised around specialised dementia services.
Approved medication
*Namzaric = combination of Donepezil and Memantine
Treatment cost
Angolan families face significant long-term dementia-care costs despite subsidised healthcare and general social assistance for vulnerable older people. Without a comprehensive dementia-specific long-term-care entitlement, households remain responsible for supervision, transport, household support, and potentially institutional care.

Public-sector healthcare provides subsidized medical care, but WHO identifies high out-of-pocket expenditure and inadequate financial protection as important continuing problems.1 Dementia creates particularly high household costs because treatment extends beyond medical consultations and medicines to include supervision, transport, household assistance and potentially institutional care Government programmes do provide some support to vulnerable older people MASFAMU reports programmes providing food support, housing assistance, social assistance and community-based support to older people. However, Angola has no comprehensive statutory dementia-specific long-term-care entitlement comparable with the long-term-care insurance systems found in some European countries Families therefore remain responsible for much of the direct and indirect cost of long-term dementia care.
Caregiver support
Angola’s dementia caregiving model is largely informal and family-based, with limited dedicated support for carers. No nationwide dementia-specific system or universal entitlement to caregiver allowances, respite, counselling, or specialised education has been identified. MASFAMU provides broader assistance to older people through programmes such as Idoso no Lar and Idoso na Comunidade, including residential, community, and social support. Organisations such as AASTI supplement these services with social and psychological assistance, but are not dementia-focused. With a limited network of Alzheimer’s or dementia-specific organisations, families have restricted access to specialised caregiver training, peer support, counselling, and respite, leaving dementia care primarily within informal family and general older-person support structures.
Family members appear to provide the majority of day-to-day dementia care in Angola, within a social-care model that places considerable emphasis on supporting older people within their families and communities. No nationwide dementia-specific caregiver support system or universal entitlement to regular respite care, dementia counselling or dedicated caregiver allowances was identified. Government support is instead delivered through broader older-person and social-protection programmes administered by the Ministry of Social Action, Family and Women’s Promotion (MASFAMU). Initiatives such as “Idoso no Lar” and “Idoso na Comunidade” aim to strengthen protection and assistance for older people in residential and community settings, while vulnerable older adults may also receive food and other forms of social assistance.
Some additional support is provided through civil-society organisations. The Associação de Amizade e Solidariedade para com a Terceira Idade (AASTI) works more broadly with older people and provides social and psychological assistance, with its activities receiving support from MASFAMU. However, AASTI is not specifically focused on dementia or dementia caregivers.2 Overall, the absence of a well-developed national network of Alzheimer’s or dementia-specific organisations means that families have relatively limited access to specialized caregiver education, counselling, peer-support groups and respite services. Dementia caregiving therefore remains largely embedded within informal family care and Angola’s broader older-person social-support system, rather than being supported by a dedicated dementia-caregiver infrastructure.
Policy
Policy
Show moreAngola’s dementia policy remains underdeveloped and integrated into broader health, ageing, and social-protection frameworks, with no dedicated National Dementia Strategy, Alzheimer’s Action Plan, or dementia-specific legislation identified as of September 2026. The WHO Angola Country Cooperation Strategy 2023–2027 prioritises stronger primary care, integrated services, NCD management, workforce development, and health-system resilience, while the National Policy for Older Persons and MASFAMU programmes provide a broader basis for addressing ageing, dependency, and family support. However, these frameworks do not establish comprehensive dementia-specific standards for diagnosis, referral, treatment, caregiving, surveillance, awareness, or research. There are signs of emerging specialist capacity: in 2025, MINSA included Alzheimer’s disease in a neuroscience capacity-building initiative, while formal training encompasses Neurology, Geriatrics, and Psychiatry. These reforms may strengthen future dementia care, but persistent fragmentation between health and social care, geographical disparities, high out-of-pocket costs, limited surveillance, and reliance on family caregiving remain significant system-level gaps.
National dementia plan
Angola lacks a dedicated National Dementia Strategy, with dementia addressed indirectly through broader healthcare, NCD, ageing, and social-protection frameworks. Current policies prioritise stronger primary and integrated care and provide support for older and vulnerable people, creating a foundation for dementia-related services. However, they do not establish dementia-specific targets, standardised diagnostic and referral pathways, treatment access, caregiver support, workforce training, surveillance, awareness, or research. Dementia therefore remains without a comprehensive and coordinated national policy framework.
Angola does not appear to have a dedicated National Dementia Strategy or Alzheimer Action Plan, with dementia instead addressed indirectly through broader policies covering primary healthcare, neurological and mental-health care, non-communicable diseases (NCDs), ageing, social protection and general health-system strengthening. The WHO Angola Country Cooperation Strategy 2023–2027 prioritizes strengthening primary healthcare, improving integrated and people-centred services across the life course, addressing NCDs and improving the overall resilience and capacity of the health system. These priorities are relevant to dementia prevention, diagnosis and management, particularly through improved primary and specialist care, but the strategy does not establish a dementia-specific national framework, targets or standardized care pathway.
Dementia is also indirectly covered by Angola’s broader policies concerning older people and social protection. The country has established a National Policy for Older Persons, while the Ministry of Social Action, Family and Women’s Promotion (MASFAMU) has reported work on a National Strategy for the Implementation of the Older Person Policy, alongside programmes intended to strengthen protection, social inclusion and assistance for older and vulnerable people. These measures provide a relevant policy foundation for dementia because they address ageing, dependency, family and community support and the social needs of older adults. However, they do not substitute for a comprehensive dementia strategy establishing specific objectives for early detection and diagnosis, clinical standards and referral pathways, access to treatment, caregiver support, professional training, epidemiological surveillance, public awareness and dementia research.
Upcoming plans
Angola is strengthening its broader health system rather than developing a dedicated dementia framework, with reforms targeting primary care, workforce development, health information, and medicine access. Dementia-relevant capacity is nevertheless expanding through neuroscience initiatives that explicitly include Alzheimer’s disease and postgraduate training in Neurology, Geriatrics, and Psychiatry. These developments could improve detection, referral, and specialist care, although no standalone national dementia strategy had been identified by September 2026.
Current reform in Angola remains focused primarily on broader health-system modernization and progress toward Universal Health Coverage (UHC) rather than the development of a dedicated dementia strategy. Key priorities include strengthening primary healthcare, expanding and training the health workforce, improving health-information systems, and reinforcing pharmaceutical regulation and access to essential medicines. These reforms could indirectly improve dementia care by increasing opportunities for earlier detection, referral and continuity of care, but they are designed to strengthen the health system as a whole rather than establish dementia-specific services or standards.
At the same time, there are indications of increasing investment in neurological and specialist capacity relevant to dementia. In 2025, the Ministry of Health (MINSA) explicitly included Alzheimer’s disease among the neurological conditions addressed through a technical neuroscience capacity-building initiative, alongside other neurological disorders.2Angola is also formalizing postgraduate specialist training through its medical internship framework, including Neurology, Geriatrics and Psychiatry, all of which are important disciplines for dementia diagnosis and management.3These developments should gradually strengthen the professional capacity available for cognitive assessment and dementia care; however, no announced standalone national dementia strategy or Alzheimer action plan was identified as of September 2026.
- https://www.afro.who.int/countries/angola/news/who-director-general-and-regional-director-africa-visit-angola-and-reinforce-commitment
- https://minsa.gov.ao/web/noticias/professor-fernando-cendes-visita-angola-no-ambito-do-reforco-das-capacidades-tecnicas-em-neurociencias
- https://sigrh.minsa.gov.ao/uploads/legislacao/internato_mdico_2025-68233bd44303f.pdf
Policy gaps
Legal barriers
Angola’s dementia care remains fragmented between general healthcare, social-protection services, and family support, without dedicated legal provisions. High household costs and geographic disparities restrict equitable access, while the apparent lack of comprehensive dementia surveillance complicates needs assessment, service monitoring, and resource planning.
Dementia care in Angola is governed indirectly through general health, ageing, disability and social-protection frameworks rather than through dedicated dementia legislation. A key structural challenge is the fragmentation between medical and social care: diagnosis and clinical treatment are provided through the health system, while long-term supervision, residential care and assistance for dependent older people remain largely within family and social-protection structures. Financial barriers further limit access, particularly where medicines, diagnostic tests or specialist services require direct household expenditure. WHO has identified health-sector underfunding and high out-of-pocket expenditure as important obstacles to equitable access and progress toward Universal Health Coverage in Angola. These problems are compounded by geographical inequalities in access to specialist and higher-level services. The apparent absence of a comprehensive national dementia registry or surveillance system also makes it more difficult to establish the scale of need, monitor service utilisation and plan dementia-specific resources.
Cultural barriers
Cultural perceptions of ageing, mental illness, and behavioural change may affect dementia recognition and help-seeking in Angola. Stigma, discrimination, and beliefs surrounding spiritual disturbance can increase vulnerability, while reliance on family and community care may leave caregiver burden, psychological stress, and respite needs less visible.
Dementia recognition and help-seeking may also be affected by broader social and cultural attitudes toward ageing, mental health and behavioural change. Cognitive decline, personality changes or unusual behaviour may not always be recognised as symptoms requiring medical assessment and can potentially be interpreted through understandings of normal ageing, mental illness or spiritual disturbance. Importantly, the Angolan government itself has highlighted wider problems affecting older people, including neglect, discrimination, violence and accusations of witchcraft, while calling for greater protection and promotion of healthy and active ageing. Such attitudes are particularly relevant to dementia because progressive cognitive and behavioural symptoms can increase vulnerability to stigma, misunderstanding and social exclusion. Strong traditions of family and community support can provide an important source of care, but heavy reliance on informal caregiving can also leave caregiver burden, psychological stress and respite needs less visible to formal health and social-service institutions.
Research
Research
Show moreAngola is strengthening the health-system foundations relevant to dementia, particularly through neuroscience capacity-building, specialist medical training, tertiary infrastructure, and health-information reform. MINSA’s 2025 initiative explicitly includes Alzheimer’s disease, while training in Neurology, Geriatrics, Psychiatry, imaging, and laboratory medicine, together with multidisciplinary capacity at the Complexo Hospitalar Cardeal Dom Alexandre do Nascimento, could improve future diagnosis and management. WHO-supported data reforms and INE’s healthy-ageing work may also strengthen planning for an ageing population. However, research and surveillance capacity remain limited. No comprehensive national dementia registry or substantial domestic Alzheimer’s therapeutic clinical-trial programme has been identified, and there is no evidence of routine participation by Angolan centres in pivotal anti-amyloid trials. National planning therefore continues to rely on hospital and broader mental-health data, alongside international epidemiological modelling. These developments provide a foundation for future progress, but capacity remains concentrated in specialist settings and requires sustained investment.
Selected academic institutions
Clinical trials and registries
No substantial domestic Alzheimer therapeutic clinical-trial programme was identified. No evidence was found of Angolan centres routinely participating in pivotal anti-amyloid trials. Angola also lacks a comprehensive national dementia registry. This means national planning relies heavily on hospital data, broader mental-health statistics and international epidemiological modelling.

Selected innovative methods
Angola is developing several system-level foundations for stronger dementia care, although these initiatives are not dementia-specific. MINSA’s 2025 neuroscience capacity-building programme explicitly includes Alzheimer’s disease and supports professional training and clinical development through international cooperation. Specialist medical training is also being expanded in Neurology, Geriatrics, Psychiatry, imaging, and laboratory medicine, while the modernised Complexo Hospitalar Cardeal Dom Alexandre do Nascimento provides multidisciplinary neurological and diagnostic capacity, including imaging, nuclear medicine, psychology, and laboratory services. Further potential lies in health-information and healthy-ageing reforms. WHO-supported improvements to national health data could strengthen planning and monitoring in a context where dementia remains under-recorded, although no dedicated dementia registry has been identified. INE’s work on the ageing population also provides evidence on older people’s demographic and socioeconomic circumstances. Together, these developments could support future improvements in dementia diagnosis, specialist care, surveillance, prevention, and long-term support, but capacity remains concentrated in specialist settings and requires sustained workforce and health-system investment.
National Neuroscience Capacity-Building Initiative: Angola’s Ministry of Health (MINSA) is strengthening national technical and professional capacity in the neurosciences, with Alzheimer’s disease, Parkinson’s disease, epilepsy and stroke explicitly identified among the neurological conditions of interest. In 2025, this included cooperation with Professor Fernando Cendes of the University of Campinas (UNICAMP), focusing on knowledge exchange, professional training and development of diagnostic and clinical capacity. Although this is not a dementia-specific programme, the explicit inclusion of Alzheimer’s disease represents an important step toward improving national expertise in dementia diagnosis and management.
Expansion of Specialist Medical Training: Angola is simultaneously expanding and formalizing its specialist medical workforce through the national medical internship framework. The framework covers disciplines directly relevant to dementia care, including Neurology, Geriatrics and Psychiatry, alongside diagnostic and supporting specialties such as radiology/imaging and laboratory medicine. Increasing the number and geographical distribution of trained specialists could gradually improve access to cognitive assessment, differential diagnosis, management of behavioural and psychological symptoms and follow-up of people with dementia, although development of this workforce will require sustained investment over time.
Modernized Tertiary Neurological Infrastructure: Investment in major referral hospitals is also increasing Angola’s capacity to investigate and manage complex neurological conditions. The Complexo Hospitalar Cardeal Dom Alexandre do Nascimento brings together neurology with neurosurgery, diagnostic imaging, nuclear medicine, clinical psychology, internal medicine and advanced laboratory services. This multidisciplinary infrastructure is relevant to dementia because complex cognitive disorders may require neurological examination, structural imaging, laboratory investigation and assessment of psychiatric or psychological symptoms. However, such advanced capacity remains part of tertiary specialist care rather than a nationwide network of dedicated memory clinics.
Health Information System Modernization: Angola is working with WHO to strengthen health-information systems, data collection and national capacity to use health information for planning and decision-making. Better routine health data could be particularly important for dementia, where limited epidemiological information and under-recording make it difficult to estimate service needs accurately. Stronger information systems could eventually support better monitoring of neurological and age-related conditions, allocation of resources and development of evidence-based dementia policies, although a dedicated national dementia registry has not been identified.
Healthy Ageing Policy Development: Population ageing is receiving greater attention within Angola’s demographic and social-policy agenda. The National Statistics Institute (INE) has produced thematic analysis of the country’s older population in the context of the United Nations Decade of Healthy Ageing (2021–2030), helping to build a stronger evidence base on the demographic and socioeconomic circumstances of older Angolans.5While this work is not dementia-specific, greater policy attention to healthy ageing, functional ability, dependency and the needs of older people provides an important foundation for the future integration of dementia prevention, diagnosis, long-term care and caregiver support into national ageing policy.
- https://minsa.gov.ao/web/noticias/professor-fernando-cendes-visita-angola-no-ambito-do-reforco-das-capacidades-tecnicas-em-neurociencias
- https://sigrh.minsa.gov.ao/uploads/legislacao/internato_mdico_2025-68233bd44303f.pdf
- https://angolex.com/paginas/decreto-executivo/estatuto-organico-do-complexo-hospitalar-de-doencas-cardiopulmonares-cardeal-dom-alexandre-do-nascimento-174a-22a.html
- https://www.who.int/about/accountability/results/who-results-report-2024-2025/country-profile/2024/angola
- https://www.ine.gov.ao/publicacoes/detalhes/NDIzNDk%3D
Support
Support
Show moreAngola is strengthening dementia-relevant capacity through broader neuroscience, ageing, social-protection, awareness, and professional-training initiatives, although these remain fragmented rather than forming a coordinated national system. Alzheimer’s disease is gaining recognition within neurological and professional education programmes, while wider ageing initiatives support vulnerable older people. Public communication remains limited, with no dedicated dementia media outlet and information mainly provided through government institutions, WHO Angola, and general media.
Selected national associations, patient family associations, NGOs:
Selected initiatives
Angola is developing dementia-relevant support through broader neuroscience, ageing, social-protection, awareness, and professional-training initiatives. MINSA’s neuroscience programme explicitly includes Alzheimer’s disease and promotes specialist capacity-building and knowledge exchange. The National Policy for Older Persons and programmes such as Idoso no Lar and Idoso na Comunidade provide wider protection and community support relevant to people with cognitive and functional decline. Healthy-ageing campaigns addressing dignity, discrimination, neglect, violence, and witchcraft accusations may provide foundations for future dementia awareness and anti-stigma efforts. Professional education is also beginning to address dementia more directly, including diagnosis and treatment in later life. However, these measures remain dispersed across broader health and social programmes rather than forming a coordinated, nationwide dementia-specific system.
National Neuroscience Strengthening Programme
National Policy for Older Persons
Idoso no Lar / Idoso na Comunidade
Healthy and Active Ageing Awareness Activities. MASFAMU has promoted public awareness around healthy and active ageing, dignity and respect for older people, while drawing attention to problems such as neglect, discrimination, violence and accusations of witchcraft affecting some older Angolans. These activities are relevant to dementia because cognitive and behavioural changes can increase vulnerability to stigma, mistreatment and social exclusion. Greater public understanding of ageing may therefore provide a foundation for future dementia-awareness and anti-stigma initiatives, even though current campaigns are not specifically focused on cognitive impairment.
Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /home/bcdafabe/public_html/wp-content/themes/bricks-child/functions.php on line 753
Professional Dementia Training
- https://minsa.gov.ao/web/noticias/professor-fernando-cendes-visita-angola-no-ambito-do-reforco-das-capacidades-tecnicas-em-neurociencias
- https://masfamu.gov.ao/web/noticias/masfamu-destaca-ac%C3%A7%C3%B5es-de-protec%C3%A7%C3%A3o-social-para-%C3%A1-pessoa-idosa
- https://masfamu.gov.ao/web/noticias/masfamu-apela-a-valoriza%C3%A7%C3%A3o-da-pessoa-idosa-e-promo%C3%A7%C3%A3o-do-envelhecimento-saud%C3%A1vel-e-activo
- https://cpsmangola.ao/programa
Dedicated media outlets
Angola does not appear to have a dedicated Alzheimer or dementia media outlet. The most authoritative dementia-related information is generally published through the Ministry of Health, MASFAMU, WHO Angola and the National Statistics Institute. General media including Jornal de Angola, ANGOP and O País periodically cover ageing, neurological disease and social-protection issues, but dementia remains a comparatively low-profile health topic.



